Brughera Marco Maria exercised Options for 15,545 FENNEC PHARMACEUTICALS shares at $2.11 per share and recorded a same-day sale at $10.29 per share. The transactions show investors how the insider’s common-share and derivative-security holdings changed, including 220,000 derivative securities after the option exercise.

Key Highlights

  • Brughera Marco Maria sold 15,545 FENNEC PHARMACEUTICALS shares at $10.29 per share.
  • The insider held 220,000 derivative securities after exercising options, representing about 6.6% of the prior derivative holding.
  • The option exercise and share sale were recorded on 15 September 2026 under transaction codes M and S.

Brughera Marco Maria exercised options for 15,545 FENNEC PHARMACEUTICALS INC. (NASDAQ: FENC) shares at $2.11 per share, with the resulting record showing ownership of 15,545 shares. The transaction was dated 15 September 2026 and classified under SEC transaction code M.

Same-Day Sale at $10.29 Per Share

A separate entry on 15 September 2026 recorded Brughera’s sale of 15,545 FENNEC PHARMACEUTICALS shares at $10.29 per share. The transaction carried SEC code S, which identifies an open-market sale. The post-transaction record showed 0 shares, and the sale represented about 100.0% of Brughera’s prior shares holding. The same date also included an option exercise involving 15,545 derivative securities. Brughera’s resulting holding stood at 220,000 derivative securities.

Common Shares and Derivative Securities Reported Separately

The records distinguish between the common shares sold and the derivative securities held after the option exercise. The derivative-securities transaction represented about 6.6% of Brughera’s prior derivative securities holding. The M code identifies the option-exercise entries, while the S code identifies the share-sale entry. Transaction code M denotes the exercise or conversion of a derivative security.